Apixiban

This is not medical advice. Always consult a licensed healthcare professional before starting or changing any treatment. Information here is based on personal experiences and may not apply to everyone.

Alternative Names: Eliquis

Apixaban is a blood thinner used to treat pulmonary embolism (PE). It helps stop clots from getting larger and lowers the risk of new clots forming in the lungs. Treatment usually begins with a higher dose for the first week, followed by a lower ongoing dose. Apixaban is effective and convenient because it does not require routine blood test monitoring, but it can increase the risk of bleeding and should be taken under medical supervision.

Treatment Type: Prescription Medication

Treatment Class: Factor Xa inhibitor

Treatment Modality: Oral

Review Summary

5.0

1 Reviews

Preferred by 1 Reviewers

Based on the review by Dr. Curbside, Apixaban (Eliquis) is highly effective in treating Pulmonary Embolism. It is recommended as a first-line treatment due to its strong protection against recurrent blood clots and lower risk of major bleeding compared to alternative medications. The drug is particularly beneficial for patients with moderate kidney problems due to its lower renal clearance.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost

3.0

1 = Very Expensive 5 = Very Affordable

3.0

Moderate Cost

Relief Speed

4.0

1 = No Relief 5 = Immediate Relief

4.0

Fast Relief

Side Effects

3.0

1 = Intolerable Effect 5 = No Effect

3.0

Moderate Effect

Treatment Line

5.0

1 = Third-line or more 5 = First-line

5.0

First-line

Choose treatments from the menu above to see how they compare side by side.

5.0

1 Reviews

100%

AI Summary of User Experiences

Not medical advice.

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost

Very Expensive

$1000+

Expensive

$501 to $1000

Moderate Cost

$101 to $500

Affordable

$25 to $100

Very Affordable

$25

Relief Speed

No Relief

No noticeable improvement

Slow Relief

Several days to weeks

Moderate Relief

Within 1 - 3 days

Fast Relief

Within hours

Immediate Relief

Within minutes

Side Effect

Intolerable Side Effect

Caused treatment to stop or required hospitalization

Severe Side Effect

Difficult to tolerate, may require intervention

Moderate Side Effect

Noticeable, but manageable

Mild Side Effect

Minor, not bothersome

No Side Effect

Without any adverse effects

Treatment Line

Third-line or more

Used after second-line failed or multiple prior treatment

Second-line

Used after first-line treatment failed or was unsuitable

First-line

First treatment tried

Dr. Curbside

Verified

Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add

1 month ago

Eliquis (apixaban) is recommended as a first-line treatment for pulmonary embolism because it offers strong protection against recurrent blood clots with a lower risk of major bleeding compared to rivaroxaban. It is often the preferred DOAC, especially in patients with moderate kidney problems, due to its lower renal clearance.

#ReviewersPreferred #ModerateCost #FastRelief #ModerateEffect #First-line #Rescue/EmergencyUse

View Professional Disclosures

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All